QSP Modeling Optimizes FIH Dose Selection for Multiple Myeloma Therapy

A Certara Case Study

Preview of the Ichnos Glenmark Innovation Case Study

Case study describing how Ichnos Glenmark Innovation used Certara

View this case study…

Ichnos Glenmark Innovation

Mario Perro

Head of Biologics Research


Certara

58 Case Studies